Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases

Mise à jour : Il y a 4 ans
Référence : NCT00875147

Femme et Homme

Extrait

Hypothesis of the study: Neoadjuvant chemotherapy with Bevacizumab impairs postoperative outcome after resection of colorectal liver metastases.


Critère d'inclusion

  • Colorectal liver metastases

Liens